Home » Archive by category "shavfgnk"

IGT lands extension with DC Lottery

first_img International Game Technology has extended its supply deal with the DC Lottery, which will see it provide instant win games and related services to the Washington DC-based lottery until December this year. Regions: US Washington DC Lottery IGT lands extension with DC Lottery 21st February 2019 | By contenteditor International Game Technology has extended its supply deal with the DC Lottery, which will see it provide instant win games and related services to the Washington DC-based lottery until December this year.Struck via its IGT Global Solutions Corporation, the renewed deal covers game planning and marketing, research and analytics, graphics support and both the production and printing of instant tickets.IGT has served as the DC Lottery’s print vendor since 2014 and last March also helped the Lottery launch its first ‘Super Ticket’ initiative.“IGT is pleased to continue working with the DC Lottery, and we look forward to enhancing their instant ticket program with creative new content over the next year,” IGT chief operating officer for lottery, Jay Gendron, said.The deal will help soften the blow of IGT seemingly missing out to rival Intralot in the race to operate regulated sports betting in the state.This week, the DC Council approved an emergency measure to bypass the public procurement process, allowing it to start contract negotiations with the Greek betting and gaming solutions provider without the need to open the process to bids from rival suppliers. Media reports suggested both IGT and Scientific Games may have been interested in bidding for the contract, had it been put to tender.Without the so-called sole-sourcing tenet, some backers of legal sports betting had warned that it could take up to three years to complete the tender process, which in turn would have meant the state missing out on millions in revenue.The sports betting legislation, which was first introduced by Councilmember Jack Evans in September 2018, and the emergency measure passed with eight votes in favour versus four against.center_img AddThis Sharing ButtonsShare to LinkedInLinkedInShare to FacebookFacebookShare to TwitterTwitter Subscribe to the iGaming newsletter Topics: Lottery Tech & innovation Email Addresslast_img read more

Continue reading »

MGM shareholder IAC outlines support for Entain deal

first_imgIAC agreed to fund a cash option for Entain shareholders that do not wish to receive share compensation as part of MGM’s proposal of 0.6 shares for every one in Entain. This would see it contribute up to $1bn towards the cash payment. Entain, formerly known as GVC, announced that MGM proposed an offer worth $11.0bn for the Ladbrokes Coral and Bwin operator, something MGM later confirmed. It also pointed out that the two businesses have complementary geographic footprints, as MGM is a major player in the US and China, whereas Entain is in much of Europe. MGM shareholder IAC outlines support for Entain deal However, Entain said that offer “substantially undervalues” the business, while MGM said it could not guarantee that it would make a firm offer before the deadline of 1 February. M&A InterActive Corp (IAC), MGM Resorts International’s largest shareholder, has pledged to contribute up to $1bn towards the land-based giant’s bid to acquire its BetMGM joint venture partner Entain. AddThis Sharing ButtonsShare to LinkedInLinkedInShare to FacebookFacebookShare to TwitterTwitter In addition, IAC said the move would allow MGM and Entain’s BetMGM joint venture greater opportunities for growth. Shares in Entain plc were trading up 0.03% at 1,467.50 pence per share in London Friday (8 January) afternoon. Shares in MGM Resorts International were trading up 1.41% at $31.03 per share, while IAC’s share price was down 0.24% at $191.03 per share.center_img Explaining its support for the deal, IAC said the combined entity would be an “omni-channel global leader” and that this would align with the future of the gambling industry. Subscribe to the iGaming newsletter Tags: MGM Resorts International Entain MGM InterActive Corporation Entain acquired a 12% stake in MGM in August 2020 for $1bn, describing the deal as a “once in a decade” opportunity. It said at the time that online gambling was the main reason for the investment, even though it made up only a “tiny portion” of MGM’s revenue at the time. 8th January 2021 | By Daniel O’Boyle Finally, it said the massive capital and cash reserves the combined business could hold would allow it to pursue further growth opportunities, including further M&A, entry into new markets and technological development. Email Address Topics: Finance Strategy M&Alast_img read more

Continue reading »

Les Moulins de la Concorde Ltee (LMLC.mu) Q12012 Interim Report

first_imgLes Moulins de la Concorde Ltee (LMLC.mu) listed on the Stock Exchange of Mauritius under the Industrial holding sector has released it’s 2012 interim results for the first quarter.For more information about Les Moulins de la Concorde Ltee (LMLC.mu) reports, abridged reports, interim earnings results and earnings presentations, visit the Les Moulins de la Concorde Ltee (LMLC.mu) company page on AfricanFinancials.Document: Les Moulins de la Concorde Ltee (LMLC.mu)  2012 interim results for the first quarter.Company ProfileLes Moulins de la Concorde Limitée (Ordinary) is headquartered in in Port-Louis, Mauritius. The company manufactures, distributes and sells wheat flour in Mauritius. Les Moulins de la Concorde Limitée exports product to Comoros, Seychelles, Reunion, Madagascar, and Mayotte as well through the company’s brand names Blédor and Les Moulins. The company also produces premix and multigrain premix flour for the manufacture of bread products under the DOMIX brand name, breads and bakery products under the OPTIMAL brand name and flour products for the manufacture of white bread under the Concorde brand name. In addition, the company provides flour for making pastries, donuts, puris, pastry flour for baking, and animal feed. Les Moulins de la Concorde Limitée (Ordinary) is listed on the Stock Exchange of Mauritius.last_img read more

Continue reading »

Jubilee Holdings Limited (JHL.ug) 2013 Annual Report

first_imgJubilee Holdings Limited (JHL.ug) listed on the Uganda Securities Exchange under the Insurance sector has released it’s 2013 annual report.For more information about Jubilee Holdings Limited (JHL.ug) reports, abridged reports, interim earnings results and earnings presentations, visit the Jubilee Holdings Limited (JHL.ug) company page on AfricanFinancials.Document: Jubilee Holdings Limited (JHL.ug)  2013 annual report.Company ProfileJubilee Holdings Limited is an investment holding company involved in all classes of general and long-term insurance. The company underwrites life and non-life insurance risks associated with death, disability, health, property and liability as well as general insurance products covering engineering, fire, marine, motor, personal accident, theft workmen’s compensation and employer’s liability, and miscellaneous insurance products. Its medical insurance division covers medical and surgical expenses; the Ordinary & Group Life division covers life assurance and superannuation business and business incidentals. Jubilee Holdings Limited issues a portfolio of investment contracts to provide asset management solutions for savings and retirement needs. The company has subsidiaries in Burundi, Kenya, Mauritius, Tanzania, Uganda and Pakistan. Jubilee Holdings Limited is listed on the Uganda Securities Exchangelast_img read more

Continue reading »

FTSE 100 stock AstraZeneca’s share price dips on blockbuster merger rumours

first_img See all posts by Kirsteen Mackay I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement. Our 6 ‘Best Buys Now’ Shares Enter Your Email Address “This Stock Could Be Like Buying Amazon in 1997” Kirsteen has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Click here to claim your copy now — and we’ll tell you the name of this Top US Share… free of charge! FTSE 100 stock AstraZeneca’s share price dips on blockbuster merger rumourscenter_img British-Swedish global pharmaceutical company AstraZeneca (LSE:AZN) is rumoured to be in talks with US drugmaker Gilead to merge. The FTSE 100 multinational approached Gilead about the deal last month. AstraZeneca’s share price was down 2% in response to the news this morning, as it appears to be nothing more than speculation at this stage. A report stated Gilead discussed the deal with its advisers, but it prefers partnerships and smaller acquisitions to a large partnership. Coronavirus treatment rivalsAstraZeneca and Gilead are currently competing to develop a coronavirus vaccine. AstraZeneca is working on a Covid-19 vaccine in collaboration with researchers at Oxford University. It reportedly received orders for 400m doses last month. It is also working on an antibody treatment.5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…And if you click here we’ll show you something that could be key to unlocking 5G’s full potential…Meanwhile, Gilead has gained approval in the US and South Korea for its highly touted drug Remdesivir, also being used to treat coronavirus. Although this has generated a good deal of positive publicity for both firms, coronavirus treatments are unlikely to result in big profits. However, a merger between the two pharma giants would create the world’s largest healthcare group, worth over £200bn.In recent months, AstraZeneca has released a string of positive updates with exciting drug releases and positive trial results. The company is on track to become the UK’s biggest company by market value, with a market capitalisation of around £110bn. The AstraZeneca share price reached £90 per share in May and remains up over 40% in a year.With such a high valuation, its price-to-earnings ratio (P/E) has reached an eye-popping 101. To give you an idea of why this is astronomically high, the average FTSE 100 P/E is around 15. Billionaire investor Warren Buffett has traditionally used a P/E of under 10 to seek a company trading below its intrinsic value. Clearly, with a P/E of 101, the AstraZeneca share price is far from undervalued. This shows possible over-confidence surrounding the share has created a bubble. Any negative news could burst the bubble, sending the share price spiralling downwards.Stock volatility and mounting pressure Research and development in the pharma sector is hugely expensive and sometimes politically sensitive. Marketing and production eats into profits and competition from generic drugs can affect sales. While a stock price often soars on rumour and anticipation of positive outcomes, equally it can plummet when trials do not reach their expected outcome. Therefore, share price volatility is to be expected and a long investment horizon is wise.The AstraZeneca share price has generally been on an upward trajectory since 2016. It has more than doubled during this time, so long-term investors that bought and held will sit on a pretty profit. However, I struggle to see how it can sustain such a high valuation. Pressure to increase scale and push innovation will continue to mount. I don’t think the AstraZeneca share price is a sensible investment at today’s price. I think there are better FTSE 100 stocks to invest in.  Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we’re offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our ‘no quibbles’ 30-day subscription fee refund guarantee. I’m sure you’ll agree that’s quite the statement from Motley Fool Co-Founder Tom Gardner.But since our US analyst team first recommended shares in this unique tech stock back in 2016, the value has soared.What’s more, we firmly believe there’s still plenty of upside in its future. In fact, even throughout the current coronavirus crisis, its performance has been beating Wall St expectations.And right now, we’re giving you a chance to discover exactly what has got our analysts all fired up about this niche industry phenomenon, in our FREE special report, A Top US Share From The Motley Fool. Kirsteen Mackay | Monday, 8th June, 2020 | More on: AZN Simply click below to discover how you can take advantage of this. Image source: Getty Images. last_img read more

Continue reading »

How a stock market recovery could boost my chances of making a million

first_imgSimply click below to discover how you can take advantage of this. Click here to claim your copy now — and we’ll tell you the name of this Top US Share… free of charge! Our 6 ‘Best Buys Now’ Shares I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement. “This Stock Could Be Like Buying Amazon in 1997” A stock market recovery has always happened following previous bear markets. As such, the long-term prospects for indexes such as the FTSE 100 are relatively attractive.Certainly, some stocks may experience further challenges due to risks such as the ongoing coronavirus pandemic. However, buying them at a discount to their intrinsic values could mean capital appreciation potential that makes it easier to generate a portfolio valued in excess of a million.5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…And if you click here we’ll show you something that could be key to unlocking 5G’s full potential…Improving investor sentiment in a stock market recoveryA stock market recovery can encourage investors to become more optimistic about the future. They may see the value of their own holdings increase, and determine that further gains are possible. A rise in share prices may also remind them that the stock market operates in cycles. No downturn or upturn has ever lasted in perpetuity. However, it is easy to forget this during periods of extreme market performance. As share prices rise, investors may become less risk-averse. This can help to sustain a bull market over the long term.As such, holders of today’s cheap stocks could benefit the most from improving sentiment. Such companies may currently be relatively unpopular due to their weak near-term outlooks. However, as investors become more tolerant of risk, they may begin to focus on undervalued companies to a greater extent. This may mean that investors who have purchased cheap stocks during the 2020 stock market crash see the value of their portfolios increase in a stock market recovery.Stronger economic conditions after the stock market crashA stock market recovery is often linked to the wider world’s economic outlook. If investors believe that economic conditions are improving, they generally become more bullish about equities.Improving economic conditions suggest that the operating environment for businesses is likely to strengthen. This may mean that those companies that have struggled to post rising sales and profit this year are able to deliver stronger financial performances. This may help to justify even higher share prices, since a higher earnings per share figure equates to a higher share price when its multiple of earnings remains constant.Clearly, company operating conditions can change quickly in a stock market recovery. However, the economy’s past performance suggests that companies are likely to rebound after the challenges experienced in 2020. Therefore, investors who have purchased struggling firms’ shares this year may benefit from an upturn in their operating outlooks in 2021 and beyond.Making a million in a market rallyEven if a stock market recovery only allows an investor to generate the market rate of return, they can still build a large portfolio over the long run. For example, the stock market has produced an annual total return of around 8% over the long run. Such a rate of return would turn £100,000 into £1m within 30 years. Similarly, a £750 monthly investment would be worth a seven-figure sum over the same period at the same return.However, through buying today’s cheap stocks and holding them ahead of a long-term stock market recovery, it may be possible to earn a higher return. Investors who have purchased undervalued stocks this year could stand to benefit the most from a likely improvement in investor sentiment and company operating conditions in the coming years. I’m sure you’ll agree that’s quite the statement from Motley Fool Co-Founder Tom Gardner.But since our US analyst team first recommended shares in this unique tech stock back in 2016, the value has soared.What’s more, we firmly believe there’s still plenty of upside in its future. In fact, even throughout the current coronavirus crisis, its performance has been beating Wall St expectations.And right now, we’re giving you a chance to discover exactly what has got our analysts all fired up about this niche industry phenomenon, in our FREE special report, A Top US Share From The Motley Fool. Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we’re offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our ‘no quibbles’ 30-day subscription fee refund guarantee. Peter Stephens | Saturday, 26th December, 2020 How a stock market recovery could boost my chances of making a million See all posts by Peter Stephens Image source: Getty Images Enter Your Email Addresslast_img read more

Continue reading »

Does this FTSE 100 company have potential for big share price growth and income?

first_img Click here to claim your copy now — and we’ll tell you the name of this Top US Share… free of charge! Enter Your Email Address “This Stock Could Be Like Buying Amazon in 1997” Does this FTSE 100 company have potential for big share price growth and income? I’m sure you’ll agree that’s quite the statement from Motley Fool Co-Founder Tom Gardner.But since our US analyst team first recommended shares in this unique tech stock back in 2016, the value has soared.What’s more, we firmly believe there’s still plenty of upside in its future. In fact, even throughout the current coronavirus crisis, its performance has been beating Wall St expectations.And right now, we’re giving you a chance to discover exactly what has got our analysts all fired up about this niche industry phenomenon, in our FREE special report, A Top US Share From The Motley Fool. See all posts by Andy Ross Andy Ross | Friday, 19th March, 2021 | More on: DGE GSK Simply click below to discover how you can take advantage of this.center_img Our 6 ‘Best Buys Now’ Shares Andy Ross owns shares in Diageo and AstraZeneca. The Motley Fool UK has recommended Diageo and GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we’re offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our ‘no quibbles’ 30-day subscription fee refund guarantee. As a long-term investor, I’m interested in the total return my investments can provide. I want those returns to exceed the market and what I could achieve if I just invested passively in an index tracker fund. This is why I want to find high-growth smaller-caps, alongside FTSE 100 companies that can provide good income and growth.FTSE 100 company with improvement potentialGlaxoSmithKline (LSE: GSK) is a pharmaceuticals giant held by a lot of private and institutional investors. Its share price has been floundering, but there are catalysts for a re-rating on the horizon.5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…And if you click here we’ll show you something that could be key to unlocking 5G’s full potential…The planned spin-out of its consumer business is the most obvious. The focus then on research and development (R&D) will put it on a potentially similar path to AstraZeneca, which has far outperformed GSK in recent years in terms of share price growth.Another would be acquisitions. GSK has already bought Tesaro to boost its oncology portfolio. Given the amount of catching up GSK needs to do, further acquisitions could boost the shares, provided they are strategic and reasonably priced. There’s some doubt over the dividend in the short term and it has been held flat for a few years. However, the discovery of blockbuster drugs (through internal R&D and acquisitions) could lead to dividend growth in the future.What are the potential downsides and reasons it might not multibag? One issue, of course, is that drugs don’t make it through trials. Another potential downside is that earnings suffer without the diversification of income that GSK currently has. That could put pressure on both the dividend and the share price, hitting shareholders with a double whammy.But I feel the GSK share price could be good value after its recent decline and I might add it to my portfolio for both income and growth.The Covid recovery shareDiageo (LSE: DGE) is a share that I already hold. I think the beverages group should bounce back strongly once lockdowns are completely lifted. That’s because it owns brands such as Johnnie Walker, Smirnoff and Guinness and a whole lot of other well-known alcoholic beverage names.When its trade customers — such as pubs, restaurants, and clubs — open again, there will be an immediate boost to earnings that has been missing for at least part of the last year. And its shares are up 60%+ over the last five years, even with the drop caused by Covid. To me that shows it can produce steady share price growth. The risks with this share are its valuation and the possibility of further Covid setbacks. Taking each in turn, the P/E is about 27, which is on the high side. But I’m happy to hold for the long term and think past performance could be replicated in the future as more people around the world enjoy drinks with strong brand names.I’d like to see the share price rebound as the economy reopens here in the UK and across other important markets (in Europe for example). However, new variations of Covid could delay that and hit Diageo’s share price.Overall though, I’m positive about Diageo and will keep it in my portfolio. I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement. Image source: Getty Images. last_img read more

Continue reading »

Currie Cup best tries mix – Round 8

first_imgMonday Aug 31, 2009 Currie Cup best tries mix – Round 8 South Africa’s premier domestic competition, the Currie Cup, is in full swing and round 8 produced a host of great tries and one major upset in particular.Argentinian wizard Juan Martin Hernandez made his home debut for the Sharks in Durban against Western Province, but it was a day to forget for the locals as Western Province took the honours 21-9.Tonderai Chavhanga got on the end of a nice try after a great counter and some quick hands. Big All Black lock Chris Jack also scored for Western Province after a nice bit of play by Bath bound Luke Watson.Hernandez himself had a pretty poor match, but did slot a trademark snap drop.The Cheetahs put in one of the performances of the weekend as they blasted away Griquas 58-13. Speedster Jongi Nokwe was on form as he scored a hatrick of tries and assisted in a few others.Nico Breedt, who spent a season at Toulon not long ago, finished off one of the tries of the match after another Nokwe break, then a great switch by Springbok Sevens star Robert Ebersohn.The Leopards picked up their first win of the season as they thrashed Boland 50-16 in Potchefstrooom, scoring a handful of great tries on the way. Wing Bom Samaai, number eight Christo van Niekerk, and scrumhalf Michael Bondesio.One of the upsets of the weekend though was the Jukskei Derby as the Lions beat the Blue Bulls 20-13 at Ellis Park, with nice tries by Jano Vermaak and Alwyn Hollenbach. Time: 05:53 Music: Pretty Thing by Evolver, and Who Do You Trust by CassetteADVERTISEMENT Posted By: rugbydump Share Send Thanks Sorry there has been an error Related Articles 81 WEEKS AGO scottish prop saves fire victim 84 WEEKS AGO New Rugby X tournament insane 112 WEEKS AGO Vunipola stands by his comments supporting… From the WebThis Video Will Soon Be Banned. Watch Before It’s DeletedSecrets RevealedGranny Stuns Doctors by Removing Her Wrinkles with This Inexpensive TipSmart Life ReportsIf You Have Ringing Ears Do This Immediately (Ends Tinnitus)Healthier Living90% of People Have No Idea What These Two Little Holes Are ForNueeyYou Won’t Believe What the World’s Most Beautiful Girl Looks Like TodayNueey10 Types of Women You Should Never MarryNueeyThe content you see here is paid for by the advertiser or content provider whose link you click on, and is recommended to you by Revcontent. As the leading platform for native advertising and content recommendation, Revcontent uses interest based targeting to select content that we think will be of particular interest to you. We encourage you to view your opt out options in Revcontent’s Privacy PolicyWant your content to appear on sites like this?Increase Your Engagement Now!Want to report this publisher’s content as misinformation?Submit a ReportGot it, thanks!Remove Content Link?Please choose a reason below:Fake NewsMisleadingNot InterestedOffensiveRepetitiveSubmitCancellast_img read more

Continue reading »

Dalkeith Residence / Hillam Architects

first_img 2015 Projects Year:  Save this picture!© Joel Barbitta+ 15 Share Dalkeith Residence / Hillam Architects 2015 ShareFacebookTwitterPinterestWhatsappMailOrhttps://www.archdaily.com/777373/dalkeith-residence-hillam-architects Clipboard ShareFacebookTwitterPinterestWhatsappMailOrhttps://www.archdaily.com/777373/dalkeith-residence-hillam-architects Clipboard Area:  1500 m² Area:  1500 m² Year Completion year of this architecture project Photographs Dalkeith Residence / Hillam ArchitectsSave this projectSaveDalkeith Residence / Hillam Architects Year:  “COPY” photographs:  Joel BarbittaPhotographs:  Joel BarbittaSave this picture!© Joel BarbittaRecommended ProductsWoodBruagBalcony BalustradesWindowsKalwall®Facades – Window ReplacementsDoorsGorter HatchesRoof Hatch – RHT AluminiumWoodTechnowoodPergola SystemsText description provided by the architects. Situated in the established inner Perth suburb of Dalkeith, the full potential of an existing 1980s brickwork house was realised by a series of dramatic alterations and additions. The expansive 1500sqm site was completely transformed to include a new driveway, gatehouse and guest wing, while the large rear garden is utilised to include a new pool, generous cabana and outbuilding.Save this picture!ElevationA new concrete canopy across the front elevation enhances the street presence of the residence while the reflection pool and stone tile path guide visitors to the entry, where a faceted timber window meets them at the front door.Save this picture!© Joel BarbittaPreserving the northern aspect of the original home was a high priority with the kitchen and main living areas to have a strong connection with the outdoors. The private areas of the house are primarily upstairs with the balcony to the master bedroom ensuring a visual connection to the tranquil pool and cabana area below.Save this picture!© Joel BarbittaNew canopies and balconies were amalgamated with existing forms and new timber finishes that bring sophistication and warmth to the project. Existing brickwork facades are concealed behind a new, restrained palette of rough sawn Victorian Cypress and dressed Blackbutt timber cladding.Save this picture!© Joel BarbittaThe rear elevation opens up to the garden with full height glazing around the ground floor perimeter that floods the main living, playroom and gym with northern light. A formal lounge room remains as a relic to the original house that serves as a new music and theatre room for its young family to retreat to.Save this picture!© Joel BarbittaThe interior finishes mirror the exterior materiality and feature Blackbutt cladding and floors to the living areas, while the curving kitchen cabinets are finished in a blackened timber veneer.Save this picture!© Joel BarbittaProject gallerySee allShow lessIddeul Kindergarten / ISON ArchitectsSelected ProjectsBIG, SANAA and Lacaton & Vassal Preselected in Competition to Design the New Aarhus …Architecture News Share Australia CopyHouses, Renovation•Dalkeith, Australia CopyAbout this officeHillam ArchitectsOfficeFollowProductsWoodSteelBrick#TagsProjectsBuilt ProjectsSelected ProjectsResidential ArchitectureHousesRefurbishmentRenovationDalkeithAustraliaPublished on November 18, 2015Cite: “Dalkeith Residence / Hillam Architects” 18 Nov 2015. ArchDaily. Accessed 11 Jun 2021. ISSN 0719-8884Browse the CatalogLouvers / ShuttersTechnowoodSunshade SystemsCompositesMitrexPhotovoltaic Solar Cladding – BIPV CladdingMetal PanelsAurubisCopper Alloy: Nordic BronzeBathroomsGeberitBathroom Series – ONESkylightsLAMILUXGlass Skylight F100 CircularMetal PanelsTrimoQbiss One in Equinix Data CentreSignage / Display SystemsGoppionDisplay Case – Q-ClassAluminium CompositesAmerican MetalcraftAluminum Panels – Decorative Fencing for BridgesPanels / Prefabricated AssembliesULMA Architectural SolutionsWater Facade PanelDoorsLinvisibileLinvisibile Concealed Sliding Door | MareaWall / Ceiling LightsiGuzziniExterior Light – WalkyWoodPlycoWood Boards – Birch LaserplyMore products »Save想阅读文章的中文版本吗?达尔基斯别墅/ Hillam Architects是否翻译成中文现有为你所在地区特制的网站?想浏览ArchDaily中国吗?Take me there »✖You’ve started following your first account!Did you know?You’ll now receive updates based on what you follow! Personalize your stream and start following your favorite authors, offices and users.Go to my stream Houses Architects: Hillam Architects Area Area of this architecture project “COPY” ArchDailylast_img read more

Continue reading »

50 fundraisers graduate from Institute of Fundraising Academy

first_img Fifty fundraisers will graduate today from the Institute of Fundraising’s Academy. They will receive their Certificates and Diplomas in Fundraising at the Institute’s first graduation ceremony, which will take place at SOAS in London.The students have spent six months studying and the successful ones will receive their certificate from Peter Lewis, CEO of the Institute of Fundraising.Since the scheme was launched in January 2011, 106 have completed the Certificate and 55 the Diploma in Fundraising.Lewis said: “Both our Certificate and Diploma are accredited by the European Fundraising Association (EFA) and are therefore recognised by employers throughout Europe.”Gill Raikes, Director of Fundraising at the National Trust, added: “The Certificate and Diploma in Fundraising have become one of the key benchmarks I use in identifying successful fundraisers. The qualifications provide them with essential background knowledge and a broader view of the profession, and give them the confidence and skills they need to progress.” 50 fundraisers graduate from Institute of Fundraising Academy Advertisement Howard Lake | 28 May 2012 | News Tagged with: Institute of Fundraising Training AddThis Sharing ButtonsShare to TwitterTwitterShare to FacebookFacebookShare to LinkedInLinkedInShare to EmailEmailShare to WhatsAppWhatsAppShare to MessengerMessengerShare to MoreAddThis  98 total views,  2 views today AddThis Sharing ButtonsShare to TwitterTwitterShare to FacebookFacebookShare to LinkedInLinkedInShare to EmailEmailShare to WhatsAppWhatsAppShare to MessengerMessengerShare to MoreAddThis About Howard Lake Howard Lake is a digital fundraising entrepreneur. Publisher of UK Fundraising, the world’s first web resource for professional fundraisers, since 1994. Trainer and consultant in digital fundraising. Founder of Fundraising Camp and co-founder of GoodJobs.org.uk. Researching massive growth in giving.  97 total views,  1 views todaylast_img read more

Continue reading »